Dr. Carlos Iribarren, MD, MPH, PhD, is a Senior Research Scientist at Kaiser Permanente, California, USA. He joined the Division of Research in 1997 and started at UCSF in 1998. A clinical epidemiologist, Dr. Iribarren's current research interests include risk stratification in the primary prevention setting, including genomic, imaging, and blood biomarkers, and the epidemiology of ECG traits (particularly QT interval) and chronic lung disease (asthma, interstitial pulmonary fibrosis). Dr. Iribarren was a standing member and co-chair of the NIH Cardiovascular, Heart, and Sleep Study Section (CHS-B) from 2017-2021 and has participated in numerous other study sections, such as the American Heart Association Behavioral Science, Epidemiology, and Prevention Study Section. He is a Consultant for the Health Care Advisors and for Abbott Diagnostics. He was a Fulbright Fellow at the University of Southern California, Los Angeles, from 1989 through 1994. Dr. Iribarren has published over 210 peer-reviewed articles.